IBEX Limited (NASDAQ:IBEX – Get Free Report) insider Christina O’Connor sold 7,500 shares of IBEX stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $40.30, for a total transaction of $302,250.00. Following the transaction, the insider directly owned 29,231 shares in the company, valued at $1,178,009.30. The trade was a 20.42% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Christina Al Trofimuk-O’connor also recently made the following trade(s):
- On Wednesday, September 16th, Christina O’Connor sold 2,376 shares of IBEX stock. The shares were sold at an average price of $39.34, for a total transaction of $93,471.84.
IBEX Stock Performance
Shares of NASDAQ:IBEX opened at $40.28 on Thursday. IBEX Limited has a 52 week low of $25.94 and a 52 week high of $42.40. The company has a market capitalization of $534.92 million, a PE ratio of 12.87 and a beta of 0.72. The company has a 50 day moving average price of $36.41 and a two-hundred day moving average price of $32.05.
Key Headlines Impacting IBEX
Here are the key news stories impacting IBEX this week:
- Positive Sentiment: IBEX announced that it won a 2026 Globee Award for excellence in an AI-powered customer-experience solution. The recognition supports the company’s positioning in the growing AI-enabled business-process-outsourcing market. ibex Wins 2026 Globee Award for AI-Powered Customer Experience Solution Excellence
- Positive Sentiment: Recent reports highlight IBEX’s efforts to use AI solutions to gain market share and adjust its delivery mix between nearshore and offshore operations. These initiatives could improve scalability, service capabilities and margins if executed successfully. IBEX touts AI solutions to grow market share IBEX shifts from nearshore to offshore
- Positive Sentiment: IBEX’s latest quarterly results modestly exceeded expectations, with earnings per share of $0.85 versus an $0.84 consensus and revenue of $164.27 million versus estimates of $160.02 million. The company reported a 7.19% net margin and 28.96% return on equity.
- Neutral Sentiment: Analyst sentiment remains cautious: Robert W. Baird raised its price target to $40 but kept a neutral rating, while the consensus rating is “Hold” with an average target of $40. The stock’s recent advance has placed it close to that consensus valuation.
- Negative Sentiment: Multiple insiders sold shares around $39.34–$40.41, including CEO Robert Dechant, COO David Afdahl, directors Mingzhe Zhuang and Daniella Ballou-Aares, and other insiders. The sales totaled more than 56,000 shares across the disclosed transactions and reduced several holdings substantially, creating a negative insider-ownership signal. Some transactions, including sales by Dechant, Afdahl and Paul Inson, were made under pre-arranged Rule 10b5-1 plans. SEC insider transaction filing
Analyst Ratings Changes
Several research firms have weighed in on IBEX. Robert W. Baird lifted their target price on IBEX from $35.00 to $40.00 and gave the stock a “neutral” rating in a report on Friday, September 11th. Wall Street Zen downgraded IBEX from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 12th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of IBEX in a report on Friday, July 31st. Three equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $40.00.
Get Our Latest Stock Analysis on IBEX
Institutional Investors Weigh In On IBEX
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Clearstead Advisors LLC lifted its position in IBEX by 159.1% during the 4th quarter. Clearstead Advisors LLC now owns 2,635 shares of the company’s stock worth $101,000 after buying an additional 1,618 shares in the last quarter. Sargent Investment Group LLC bought a new position in shares of IBEX in the 4th quarter valued at about $249,000. Valued Retirements Inc. bought a new position in shares of IBEX in the 4th quarter valued at about $289,000. Evolve Private Wealth LLC increased its position in shares of IBEX by 5.7% in the first quarter. Evolve Private Wealth LLC now owns 10,280 shares of the company’s stock valued at $276,000 after acquiring an additional 555 shares during the last quarter. Finally, Pinnacle Wealth Management Advisory Group LLC increased its position in shares of IBEX by 33.0% in the second quarter. Pinnacle Wealth Management Advisory Group LLC now owns 10,576 shares of the company’s stock valued at $321,000 after acquiring an additional 2,625 shares during the last quarter. 81.24% of the stock is currently owned by institutional investors and hedge funds.
IBEX Company Profile
IBEX Limited (NASDAQ: IBEX) is a global business process outsourcing and customer experience company. It provides digitally enabled customer support and operational services for brands across industries including e-commerce, health and fitness, fintech, logistics, retail, travel and utilities.
The company’s services include customer care, technical support, sales and customer acquisition, back-office processing, trust and safety, and other specialized business support functions. IBEX combines contact center personnel, analytics, automation and artificial intelligence-enabled tools to help clients manage customer interactions across voice, digital and other communication channels.
IBEX serves clients primarily in North America and other international markets through delivery operations in locations including the United States, the Philippines, Jamaica, Nicaragua and Pakistan.
Read More
- Five stocks we like better than IBEX
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for IBEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBEX and related companies with MarketBeat.com's FREE daily email newsletter.
